Skip to content
HowShorted

Accelerate Diagnostics, Inc short interest in 2020

In 2020, Accelerate Diagnostics, Inc's disclosed short interest ran from 28.89% of shares outstanding on 15 Jan 2020 to 24.13% on 31 Dec 2020, a change of -4.76 percentage points. The year's high was 31.31% on 30 Jun 2020 and its low 24.10% on 15 Dec 2020, averaging 27.99% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 117.42 days on 14 Feb 2020. Full history: Accelerate Diagnostics, Inc.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025

Aggregate net short position time series for Accelerate Diagnostics, Inc in 2020

2020 in figures

Start of year
28.89% (15 Jan 2020)
End of year
24.13% (31 Dec 2020)
Change
-4.76 pp
High
31.31% (30 Jun 2020)
Low
24.10% (15 Dec 2020)
Average
27.99%
Highest days to cover
117.42 (14 Feb 2020)
SEC filings marked
9

Every report in 2020

Accelerate Diagnostics, Inc short interest in 2020
SettlementShort interestDays to coverFilings since previous
15 Jan 202028.89%98.44results (8-K)
31 Jan 202028.35%79.42
14 Feb 202028.32%117.42
28 Feb 202028.10%55.21results (8-K), 10-K filed
13 Mar 202028.26%46.06
31 Mar 202028.10%18.68
15 Apr 202028.87%43.89
30 Apr 202030.45%38.15results (8-K)
15 May 202030.41%43.27results (8-K), 10-Q filed
29 May 202030.32%61.57
15 Jun 202030.77%36.53
30 Jun 202031.31%26.47
15 Jul 202028.52%31.44
31 Jul 202028.44%46.78
14 Aug 202027.23%65.9210-Q filed
31 Aug 202026.35%31.40
15 Sep 202026.47%41.88
30 Sep 202027.81%76.67
15 Oct 202027.73%92.77
30 Oct 202027.56%100.60
13 Nov 202026.08%59.2510-Q filed, results (8-K)
30 Nov 202025.21%68.36
15 Dec 202024.10%40.46
31 Dec 202024.13%54.14

See also: Accelerate Diagnostics, Inc's full history · most shorted US stocks of 2020 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.